| For Renal Cell Carcinoma, Most Surveyed European Oncologists Would Switch From ... - DigitalJournal.com (press release) |
|
|
DigitalJournal.com (press release)The new European Physician & Payer Forum report entitled The Next Wave of Targeted Agents for Renal Cell Carcinoma: Insights from European Payers and ... read more |